South & Central America dPCR and qPCR Market Forecast to 2030

South & Central America dPCR and qPCR Market Forecast to 2030

South & Central America dPCR and qPCR Market Forecast to 2030 – Regional Analysis – By Treatment [Quantitative PCR (qPCR) and Digital PCR (dPCR)], Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), and End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)

Send Enquiry
Item ID: BMIRE00029882 Category: Tag:

$2,840 – $4,440

Description

The South & Central America dPCR and qPCR market was valued at US$ 579.36 million in 2022 and is expected to reach US$ 974.29 million by 2030; it is estimated to grow at a CAGR of 6.7% from 2022 to 2030.

Growing Adoption of PCR Methods in Emerging Countries Drive South & Central America dPCR and qPCR Market

In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the South & Central America dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.

South & Central America dPCR and qPCR Market Overview

Cancer is one of the significant causes of mortality in Brazil. In the last few years, cancer cases have increased across the country. According to Revista Brasileira de Cancerologia, in 2023, there will be 7.04 million new cases of cancer in Brazil. Further, dPCR and qPCR are major tools for cancer diagnosis, and technological advancements in these tools enhance the diagnosis. Also, the increasing incidence of yellow fever is a public health concern in Brazil. Three countries in the Americas reported confirmed cases of yellow fever in 2022 between epidemiological week (EW) 1 and EW 52: Bolivia (5 confirmed cases), Brazil (5 cases and 4 deaths during the seasonal period of 2021-2022), and Peru (7 confirmed cases, including 5 deaths). dPCR and qPCR methods offer rapid, sensitive, and highly specific detection of the yellow fever virus. Thus, an increase in cancer and yellow fever cases bolster the deployment of dPCR and qPCR solutions across Brazil.

South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

South & Central America dPCR and qPCR Market Segmentation

The South & Central America dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the South & Central America dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the South & Central America dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the South & Central America dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the South & Central America dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the South & Central America dPCR and qPCR market is segmented into segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America dPCR and qPCR market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Standard BioTools Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America dPCR and qPCR market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 6.7% CAGR, the South & Central America dPCR and qPCR Market is Speculated to be Worth US$ 974.29 Million by 2030, Says the Research Team

According to the Research Team’ research, the South & Central America dPCR and qPCR market was valued at US$ 579.36 million in 2022 and is expected to reach US$ 974.29 million by 2030, registering a CAGR of 6.7% from 2022 to 2030. Development of droplet digital PCR and growing adoption of PCR methods in emerging countries are among the critical factors attributed to the South & Central America dPCR and qPCR market expansion.

Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, development of ddPCR would become a major trend in the South & Central America dPCR and qPCR market in the future.

On the contrary, high costs of PCR systems hampers the growth of South & Central America dPCR and qPCR market.

Based on treatment, the South & Central America dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held 69.4% share of the South & Central America dPCR and qPCR market in 2022, amassing US$ 401.85 million. It is projected to garner US$ 698.52 million by 2030 to expand at 7.2% CAGR during 2022-2030.

By product, the South & Central America dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 62.9% share of the South & Central America dPCR and qPCR market in 2022, amassing US$ 364.65 million. It is projected to garner US$ 643.11 million by 2030 to expand at 7.3% CAGR during 2022-2030.

By application, the South & Central America dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held 57.9% share of the South & Central America dPCR and qPCR market in 2022, amassing US$ 335.73 million. It is projected to garner US$ 629.50 million by 2030 to expand at 8.2% CAGR during 2022-2030. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the South & Central America dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held 57.9% share of the South & Central America dPCR and qPCR market in 2022, amassing US$ 335.73 million. It is projected to garner US$ 629.50 million by 2030 to expand at 8.2% CAGR during 2022-2030.

Based on country, the South & Central America dPCR and qPCR market is segmented into segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil held 61.5% share of South & Central America dPCR and qPCR market in 2022, amassing US$ 356.22 million. It is projected to garner US$ 631.56 million by 2030 to expand at 7.4% CAGR during 2022-2030.

Key players operating in the South & Central America dPCR and qPCR market are Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Standard BioTools Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America dPCR and qPCR market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in South & Central America dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the dPCR and qPCR market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America dPCR and qPCR Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
5. South & Central America dPCR and qPCR Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Genetic and Infectious Diseases
5.1.2 Rising Investments and Funds for Gene Synthesis
5.1.3 Technological Advancements in PCR Technologies
5.2 Market Restraints
5.2.1 High Costs of PCR Systems
5.2.2 Technical Limitations Associated with qPCR
5.3 Market Opportunities
5.3.1 Growing Adoption of PCR Methods in Emerging Countries
5.4 Future Trends
5.4.1 Development of Droplet Digital PCR
5.5 Impact Analysis:
6. dPCR and qPCR Market – South & Central America Market Analysis
6.1 South & Central America dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 South & Central America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Quantitative PCR
7.3.1 Overview
7.3.2 Quantitative PCR: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Digital PCR
7.4.1 Overview
7.4.2 Digital PCR: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 – by Product
8.1 Overview
8.2 South & Central America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
8.3 Reagents & Consumables
8.3.1 Overview
8.3.2 Reagents & Consumables: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Software & Services
8.5.1 Overview
8.5.2 Software & Services: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 South & Central America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Research Application
9.3.1 Overview
9.3.2 Research Application: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Clinical Application
9.4.1 Overview
9.4.2 Clinical Application: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 South & Central America dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
9.5 Forensic Application
9.5.1 Overview
9.5.2 Forensic Application: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 – by End-User
10.1 Overview
10.2 South & Central America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
10.3 Hospitals and Diagnostic Centers
10.3.1 Overview
10.3.2 Hospitals and Diagnostic Centers: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biotechnology Companies: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research Laboratories and Academic Institutes
10.5.1 Overview
10.5.2 Research Laboratories and Academic Institutes: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Forensic Laboratories
10.6.1 Overview
10.6.2 Forensic Laboratories: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.7 Clinical Research Organizations
10.7.1 Overview
10.7.2 Clinical Research Organizations: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
11. South & Central America dPCR and qPCR Market – Country Analysis
11.1.1.1 South & Central America dPCR and qPCR Market, by Country
11.1.1.2 Brazil
11.1.1.2.1 Brazil: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 Brazil: South & Central America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.2.3 Brazil: South & Central America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.2.4 Brazil: South & Central America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.2.4.1 Brazil: South & Central America dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.2.5 Brazil: South & Central America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.3 Argentina
11.1.1.3.1 Argentina: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 Argentina: South & Central America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.3.3 Argentina: South & Central America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.3.4 Argentina: South & Central America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.3.4.1 Argentina: South & Central America dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.3.5 Argentina: South & Central America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.4 Rest of South & Central America
11.1.1.4.1 Rest of South & Central America: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 Rest of South & Central America: South & Central America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.4.3 Rest of South & Central America: South & Central America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.4.4 Rest of South & Central America: South & Central America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.4.4.1 Rest of South & Central America: South & Central America dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.4.5 Rest of South & Central America: South & Central America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
12. dPCR and qPCR Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in South & Central America dPCR and qPCR Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takara Bio Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Qiagen NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Standard BioTools Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 F. Hoffmann-La Roche Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bio-Rad Laboratories Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Agilent Technologies Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. South & Central America dPCR and qPCR Market Segmentation
Table 2. South & Central America dPCR and qPCR Market, by Clinical Application – Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: South & Central America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: South & Central America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: South & Central America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil: South & Central America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil: South & Central America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina: South & Central America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina: South & Central America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: South & Central America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina: South & Central America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina: South & Central America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America: South & Central America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America: South & Central America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America: South & Central America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: South & Central America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America: South & Central America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Organic Growth Strategies in South & Central America dPCR and qPCR Market
Table 19. Recent Inorganic Growth Strategies in the South & Central America dPCR and qPCR Market
Table 20. Glossary of Terms, South & Central America dPCR and qPCR Market

LIST OF FIGURES

Figure 1. South & Central America dPCR and qPCR Market Segmentation, By Country
Figure 2. South & Central America – PEST Analysis
Figure 3. South & Central America dPCR and qPCR Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. South & Central America dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
Figure 6. South & Central America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 7. Quantitative PCR: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Digital PCR: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 10. Reagents & Consumables: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Instruments: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Software & Services: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. South & Central America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 14. Research Application: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Clinical Application: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Forensic Application: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. South & Central America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 18. Hospitals and Diagnostic Centers: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Pharmaceutical and Biotechnology Companies: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Research Laboratories and Academic Institutes: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Forensic Laboratories: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Clinical Research Organizations: South & Central America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. South & Central America dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 24. South & Central America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 25. Brazil: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Argentina: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Rest of South & Central America: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Growth Strategies in South & Central America dPCR and qPCR Market

The List of Companies – South & Central America dPCR and qPCR Market

1. Abbott Laboratories
2. Thermo Fisher Scientific Inc
3. Takara Bio Inc
4. Qiagen NV
5. Standard BioTools Inc
6. Agilent Technologies Inc
7. F. Hoffmann-La Roche Ltd
8. Bio-Rad Laboratories Inc

Reviews

There are no reviews yet.

Be the first to review “South & Central America dPCR and qPCR Market Forecast to 2030”